Keith T. Flaherty, Director at Loxo Oncology, Inc. (LOXO), sold 14,500 shares at $41.45 ($601K) on 2017-02-21, disclosed to the SEC on 2017-02-23.
Open-market sale of $601k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.45 | 7,250 | $301K | 50.0% |
| 2 | $41.45 | 7,250 | $301K | 50.0% |
| Total | $41.45 avg | 14,500 | $601K | 100% |
| Filing → |
| LOXO | SELL | 2017-08-23 | $775K | — | Filing → |
| LOXO | SELL | 2017-05-24 | $649K | — | Filing → |
| LOXO | SELL | 2016-12-21 | $438K | — | Filing → |